PMCPA Case
| Case | AUTH/2731/9/14 |
| Complainant | Pulmonologist (working in Germany) |
| Company | Boehringer Ingelheim |
| Event | Scientific satellite symposium at ERS Congress, Munich |
| Session title (as advertised) | “Slowing disease progression in IPF: New evidence From Phase III clinical trials” |
| Main issue | Beer appeared to be consumed on stage; overall impression deemed unacceptable/inappropriate subsistence |
| UK involvement | 2 of 4 speakers were UK health professionals; 63 UK respiratory health professionals sponsored to attend ERS Congress |
| Applicable Code year | 2014 |
| Clauses considered by Authority | 7.2, 9.1, 12.1 |
| Breach(es) | Clause 9.1 |
| Sanctions | Undertaking received; additional sanctions not stated |
| Complaint received | 16 September 2014 |
| Case completed | 19 January 2015 |
| Appeal | No appeal |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.